ישראל - עברית - Ministry of Health

abbott medical laboratories ltd - niacin 500 mg - film coated tablets - extended release - nicotinic acid - therapy with lipid-altering agents should be only one component of multiple risk factor intervention in individuals at significantly increased risk for atherosclerotic vascular disease due to hyperlipidemia. niacin therapy is indicated as an adjunct to diet when the response to a diet restricted in saturated fat and cholesterol and other nonpharmacologic measures alone has been inadequate. 1.niaspan is indicated to reduce elevated tc, ldl-c, apo b and tg levels, and to increase hdl-c in patients with primary hyperlipidemia and mixed dyslipidemia. 2.niaspan in combination with simvastatin or lovastatin is indicated for the treatment of primary hyperlipidemia and mixed dyslipidemia when treatment with niaspan, simvastatin, or lovastatin monotherapy is considered inadequate. 3.in patients with a history of myocardial infarction and hyperlipidemia, niacin is indicated to reduce the risk of recurrent nonfatal myocardial infarction. 4.in patients with a history of coronary artery disease (cad) and hyperlipidemia, n

ישראל - עברית - Ministry of Health

abbott medical laboratories ltd - niacin 750 mg - film coated tablets - extended release - nicotinic acid - therapy with lipid-altering agents should be only one component of multiple risk factor intervention in individuals at significantly increased risk for atherosclerotic vascular disease due to hyperlipidemia. niacin therapy is indicated as an adjunct to diet when the response to a diet restricted in saturated fat and cholesterol and other nonpharmacologic measures alone has been inadequate. 1.niaspan is indicated to reduce elevated tc, ldl-c, apo b and tg levels, and to increase hdl-c in patients with primary hyperlipidemia and mixed dyslipidemia. 2.niaspan in combination with simvastatin or lovastatin is indicated for the treatment of primary hyperlipidemia and mixed dyslipidemia when treatment with niaspan, simvastatin, or lovastatin monotherapy is considered inadequate. 3.in patients with a history of myocardial infarction and hyperlipidemia, niacin is indicated to reduce the risk of recurrent nonfatal myocardial infarction. 4.in patients with a history of coronary artery disease (cad) and hyperlipidemia, n

ישראל - עברית - Ministry of Health

abbott medical laboratories ltd - niacin 1000 mg - film coated tablets - extended release - nicotinic acid - therapy with lipid-altering agents should be only one component of multiple risk factor intervention in individuals at significantly increased risk for atherosclerotic vascular disease due to hyperlipidemia. niacin therapy is indicated as an adjunct to diet when the response to a diet restricted in saturated fat and cholesterol and other nonpharmacologic measures alone has been inadequate. 1.niaspan is indicated to reduce elevated tc, ldl-c, apo b and tg levels, and to increase hdl-c in patients with primary hyperlipidemia and mixed dyslipidemia. 2.niaspan in combination with simvastatin or lovastatin is indicated for the treatment of primary hyperlipidemia and mixed dyslipidemia when treatment with niaspan, simvastatin, or lovastatin monotherapy is considered inadequate. 3.in patients with a history of myocardial infarction and hyperlipidemia, niacin is indicated to reduce the risk of recurrent nonfatal myocardial infarction. 4.in patients with a history of coronary artery disease (cad) and hyperlipidemia, n

ישראל - עברית - Ministry of Health

manon pharm ltd. - ascorbic acid; betacarotene; biotin; calcium carbonate; calcium pantothenate; chromium as chloride; colecalciferol; copper; cyanocobalamin; ferrous fumarate; folic acid; magnesium oxide; manganese as sulfate; nicotinamide; potassium iodide; pyridoxine (vit b6) hydrochloride; riboflavine; sodium molybdate; sodium selenate; thiamine (vit b1) mononitrate; tocopherol (vit e) (as tocopheryl acetate); vitamin a; zinc as oxide - טבליה - betacarotene 1500 iu; vitamin a 1500 iu; ascorbic acid 100 mg; folic acid 1 mg; riboflavine 3.4 mg; nicotinamide 20 mg; cyanocobalamin 12 mcg; colecalciferol 250 iu; biotin 30 mcg; copper 2 mg; sodium molybdate 25 mcg; manganese as sulfate 5 mg; zinc as oxide 25 mg; ferrous fumarate 60 mg; potassium iodide 0.15 mg; magnesium oxide 50 mg; chromium as chloride 25 mcg; calcium pantothenate 10 mg; pyridoxine (vit b6) hydrochloride 10 mg; thiamine (vit b1) mononitrate 3 mg; tocopherol (vit e) (as tocopheryl acetate) 30 iu; calcium carbonate 250 mg; sodium selenate 25 mcg - vitamin and mineral supplement for use during pregnancy and lactation.

ישראל - עברית - Ministry of Health

abbott medical laboratories ltd, israel - ferrous sulfate; folic acid - טבליה - folic acid 0.35 mg; ferrous sulfate 325.0 mg - folic acid, combinations - folic acid, combinations - for the treatment and prevention of iron deficiency anaemia and for the prevention of folic acid deficiency in non-pregnant adults.

ישראל - עברית - Ministry of Health

novartis israel ltd - zoledronic acid - תמיסה לאינפוזיה - zoledronic acid 5 mg / 100 ml - zoledronic acid - zoledronic acid - treatment of paget's disease of the bone. treatment of osteoporosis : - in post-menopausal women - in men at increased risk of fracture including those with a recent low-trauma hip fracture.treatment and prevention of glucocorticoid-induced osteoporosis.prevention of postmenopausal osteoporosis in women for whom bisphosphonate therapy is indicated.

ישראל - עברית - Ministry of Health

cts chemical industries ltd, israel - ferrous as iron iii hydroxide polymaltose compl.; folic acid - טבליה - folic acid 0.4 mg; ferrous as iron iii hydroxide polymaltose compl. 100 mg - ferrous amino acid complex - ferrous amino acid complex - prevention and treatment of anemia caused by iron and folic acid deficiency including anemia of pregnancy and lactation.

ישראל - עברית - Ministry of Health

rekah pharmaceutical industry ltd, israel - folic acid - טבליה - folic acid 10 mg - folic acid - folic acid - treatment of folic acid deficiency megaloblastic anemia in malabsorption states.

ישראל - עברית - Ministry of Health

cts chemical industries ltd, israel - folic acid - טבליה - folic acid 5 mg - folic acid - folic acid - prevention and treatment of folic acid deficiency.

ישראל - עברית - Ministry of Health

abic marketing ltd, israel - risedronic acid as sodium - טבליות מצופות פילם - risedronic acid as sodium 150 mg - risedronic acid - risedronic acid - treatment of postmenopausal osteoporosis.prevention of postmenopausal osteoporosis.